New Delhi, Jan. 28 -- Pharma major Cipla on Tuesday reported 50 per cent jump in net profit at
Rs 1,571 crore year-on-year basis during third quarter (October-December) of current fiscal 2024-25, versus Rs 1,049 crore in the corresponding quarter of last fiscal that is 2023-24.
The income from operations grew 8 per cent year-on-year at Rs 7,073 crore during the reporting quarter as against Rs 6,544 crore in the corresponding period of last financial year, the company said in a regulatory filing with the stock exchanges.
"I am pleased to share that we continue to make considerable progress across our focused markets. In Q3FY25, we delivered growth across all our various geographies, despite of a supply challenge in the U.S. We recorded a ...